Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ÌìÃÀ´«Ã½ Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
ÌìÃÀ´«Ã½ Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Disruption of proteostatic networks in Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
David R Borchelt and Guilian Xu
J Alzheimers Dis Parkinsonism
DOI:
Atsushi Nagai, Abdullah Md Sheikh, Shatera Tabassum, Shozo Yano, Takafumi Ikeue, Makoto Handa
J Alzheimers Dis Parkinsonism
DOI:
Ji Zhong Bai and Janusz Lipski
Common risk factors for Alzheimer�s disease and vascular dementia
J Alzheimers Dis Parkinsonism
DOI:
Ken Nagata, Takashi Yamazaki and Daiki Takano
J Alzheimers Dis Parkinsonism
DOI:
Rosanna Squitti
Body mass index and risk of future dementia over two decades in two million people
J Alzheimers Dis Parkinsonism
DOI:
Qizilbash Nawab, Gregson J, Johnson M, Pearce N, Douglas I, Wing K, Evans S J W and Pocock S
Traumatic Brain Injury (TBI) as a missed cause of Dementia
J Alzheimers Dis Parkinsonism
DOI:
Anne Felicia Ambrose
Addressing nutritional requirements in early Alzheimer�s disease: What, why and when?
J Alzheimers Dis Parkinsonism
DOI:
Laus Broersen
J Alzheimers Dis Parkinsonism
DOI:
Piotr Lewczuk
Altered copper metabolism as a theranostic biomarker in neurodegeneration
J Alzheimers Dis Parkinsonism
DOI:
Fangyu Peng
The Aβ oligomer count in CSF is a useful biomarker for Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Dieter Willbold
J Alzheimers Dis Parkinsonism
DOI:
Fabrizio Piazza, S M Greenberg, A Lleo Bisa, J F Vazquez Costa, R Nitrini, A Kakita, Y Hagiwara, G Giaccone, G Boncoraglio, M Glatzel, C Marini1, A Uncini, S Cirillo, F Tagliavini, C Ferrarese and J C DiFrancesco
J Alzheimers Dis Parkinsonism
DOI:
Shigeru Sase
PZP: A novel biomarker for early Alzheimer�s disease?
J Alzheimers Dis Parkinsonism
DOI:
Diana A T Nijholt
Unexpected brain MRI abnormalities in aging research studies
J Alzheimers Dis Parkinsonism
DOI:
Howard A Rowley
Tau PET imaging: New insight into early diagnosis of tauopathy
J Alzheimers Dis Parkinsonism
DOI:
Naruhiko Sahara
Early dysfunctions preceding neurodegeneration in synucleinopathy
J Alzheimers Dis Parkinsonism
DOI:
Elvira De Leonibus
Alzheimer disease and neuroplasticity: New approaches and new targets
J Alzheimers Dis Parkinsonism
DOI:
Tayfun Uzbay
J Alzheimers Dis Parkinsonism
DOI:
Filippo Caraci
Stealth adapted viruses, alternative cellular energy (ACE) pathway and Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
W John Martin
The role of apoptotic mechanisms in the pathophysiology of Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Rona K Graham
J Alzheimers Dis Parkinsonism
DOI:
James A Duce
P53 family pathway activation in microglia; implications for neurodegeneration
J Alzheimers Dis Parkinsonism
DOI:
Jennifer Pocock
Optogenetic investigation of brain network dysfunction in Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Mondragon-Rodriguez Siddhartha
J Alzheimers Dis Parkinsonism
DOI:
Calsolaro Valeria, Pasqualetti Giuseppe, Tognini Sara, Polini Antonio, Cottone Silvia, Bini Giacomo1, Atteo Elisabetta, De Feo Paola1, Meucci Giuseppe and Monzani Fabio
A prophylactic daily program for dementia
J Alzheimers Dis Parkinsonism
DOI:
Toru Itakura and Yoshihito Owai
J Alzheimers Dis Parkinsonism
DOI:
Hansotto Reiber, Peter Lange and Inga Zerr
Genetic modifiers of repeat expansions in C9ORF72
J Alzheimers Dis Parkinsonism
DOI:
Markavan Blitterswijk
Dementia in children and young adults with Niemann-Pick disease type C (NPC)
J Alzheimers Dis Parkinsonism
DOI:
Jacqueline Imrie
Managing mood and behaviors in long-term care facilities in the United States
J Alzheimers Dis Parkinsonism
DOI:
Eric G Tangalos
J Alzheimers Dis Parkinsonism
DOI:
Sanjay Asthana, Carey Gleason, Maritza Dowling and Whitney Wharton
J Alzheimers Dis Parkinsonism
DOI:
Eef Hogervorst
Vitamin B12 deficiency and cognitive impairment: Re-visiting an old acquaintance
J Alzheimers Dis Parkinsonism
DOI:
Belinda Vicioso
Indicators of quality of care for patients with dementia in the acute care setting
J Alzheimers Dis Parkinsonism
DOI:
Melinda Martin Khan
J Alzheimers Dis Parkinsonism
DOI:
Attila Lawrence
Latent Herpes virus infection cognitive deterioration and dementia
J Alzheimers Dis Parkinsonism
DOI:
Federico Licastro
Long-term ongoing structured support in early stage of dementia: PER-model
J Alzheimers Dis Parkinsonism
DOI:
Annika Kjallman Alm
Black and minority ethnic communities and dementia: Where are we now?
J Alzheimers Dis Parkinsonism
DOI:
Truswell David
Dementia and public health: Promise, pitfalls and progress
J Alzheimers Dis Parkinsonism
DOI:
Melinda Martin Khan, Travers C, Halliday L and Lie D
J Alzheimers Dis Parkinsonism
DOI:
Neli Petrova, S Mehrabian, M Raycheva and L Traykov
What are the prospects of slowing the progression of Alzheimer�s disease?
J Alzheimers Dis Parkinsonism
DOI:
Alan M Palmer
J Alzheimers Dis Parkinsonism
DOI:
Barbara C Fisher
Amylin: What might be its role in Alzheimer�s disease and how could this affect therapy?
J Alzheimers Dis Parkinsonism
DOI:
Charles De Carli
J Alzheimers Dis Parkinsonism
DOI:
Florindo Stella
Insulin-like growth factor II reverses memory and synaptic impairments in APP transgenic mice
J Alzheimers Dis Parkinsonism
DOI:
Ana Gracia Osta, Garcia-Barroso C, Ugarte A, Oyarazabal J and Mar Cuadrado-Tejedor
Epigenetic approaches for the treatment of Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Mar Cuadrado-Tejedor, Carolina Garcia-Barroso, Julen Oyarzabal and Ana Garcia-Osta
J Alzheimers Dis Parkinsonism
DOI:
Lydia Gimenez Llort
J Alzheimers Dis Parkinsonism
DOI:
John A Schetz
J Alzheimers Dis Parkinsonism
DOI:
Laura Morelli
New cellular models for drug discovery in Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Jordan L Holtzman
Involvement of PKR in Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Jacques Hugon, Julien Dumurgier, Fran�ois Mouton-Liger, Pauline Lapalus, Magali Prevot, Sandrine Indart, Jean Louis Laplanche and Claire Paquet
Development of polysorbate-80 coated galantamine nanorticles to treat Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
C Vijaya Raghavan, N Tamilselvan, K Balakumar, Siram Karthik
Make the best use of Scientific Research and information from our 700 + peer reviewed, ÌìÃÀ´«Ã½ Access Journals